0002007317-24-000206.txt : 20240226 0002007317-24-000206.hdr.sgml : 20240226 20240226162258 ACCESSION NUMBER: 0002007317-24-000206 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240226 DATE AS OF CHANGE: 20240226 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc. CENTRAL INDEX KEY: 0001567514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 364742850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36274 FILM NUMBER: 24679229 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-923-3344 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Oneida Resources Corp. DATE OF NAME CHANGE: 20130122 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Neumann Mark CENTRAL INDEX KEY: 0001756211 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O INTRA-CELLULAR THERAPIES, INC. STREET 2: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 144 1 primary_doc.xml 144 0001756211 XXXXXXXX LIVE 0001567514 Intra-Cellular Therapies, Inc. 001-36274 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344 Neumann Mark Officer Common Merrill Lynch

75 Rockefeller Plaza New York NY 10019

7907 554008.86 96807191 02/26/2024 nasdaq COMMON 02/23/2021 COMPENSATION MARK NEUMANN N 7907 02/26/2024 COMPENSATION N MARK NEUMANN

430 EAST 29TH STREET NEW YORK NY 10016

COMMON 02/02/2024 11860 795670.96 Mark Neumann

430 EAST 29TH STREET NEW YORK NY 10016

COMMON 11/06/2023 26754 1496117.34 02/26/2024 03/14/2023 MARK NEUMANN